オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/06 | 2,226 | 2,235 | 2,033 | 2,041 | -170 | -7.7% | 951,000 |
2020/08/05 | 2,131 | 2,235 | 2,113 | 2,211 | +78 | +3.7% | 631,900 |
2020/08/04 | 2,086 | 2,172 | 2,076 | 2,133 | +47 | +2.3% | 573,200 |
2020/08/03 | 2,015 | 2,096 | 2,001 | 2,086 | +61 | +3% | 419,000 |
2020/07/31 | 2,076 | 2,141 | 2,015 | 2,025 | -82 | -3.9% | 755,500 |
2020/07/30 | 2,076 | 2,132 | 2,018 | 2,107 | +21 | +1% | 708,600 |
2020/07/29 | 2,154 | 2,172 | 2,063 | 2,086 | -69 | -3.2% | 570,200 |
2020/07/28 | 2,175 | 2,231 | 2,115 | 2,155 | -26 | -1.2% | 562,000 |
2020/07/27 | 2,326 | 2,330 | 2,176 | 2,181 | -163 | -7% | 848,200 |
2020/07/22 | 2,330 | 2,360 | 2,245 | 2,344 | +7 | +0.3% | 491,900 |
2020/07/21 | 2,303 | 2,365 | 2,282 | 2,337 | +36 | +1.6% | 590,100 |
2020/07/20 | 2,308 | 2,350 | 2,230 | 2,301 | -17 | -0.7% | 763,400 |
2020/07/17 | 2,390 | 2,431 | 2,280 | 2,318 | -81 | -3.4% | 994,600 |
2020/07/16 | 2,548 | 2,550 | 2,396 | 2,399 | -129 | -5.1% | 1,018,400 |
2020/07/15 | 2,542 | 2,568 | 2,465 | 2,528 | +5 | +0.2% | 669,500 |
2020/07/14 | 2,560 | 2,666 | 2,481 | 2,523 | -27 | -1.1% | 1,064,200 |
2020/07/13 | 2,583 | 2,592 | 2,476 | 2,550 | -33 | -1.3% | 753,900 |
2020/07/10 | 2,620 | 2,707 | 2,525 | 2,583 | -37 | -1.4% | 1,175,400 |
2020/07/09 | 2,855 | 2,881 | 2,611 | 2,620 | -245 | -8.6% | 1,747,400 |
2020/07/08 | 2,886 | 2,939 | 2,793 | 2,865 | -7 | -0.2% | 1,036,900 |
2020/07/07 | 2,762 | 2,906 | 2,760 | 2,872 | +10 | +0.3% | 1,259,900 |
2020/07/06 | 3,025 | 3,040 | 2,806 | 2,862 | -248 | -8% | 1,713,200 |
2020/07/03 | 2,911 | 3,160 | 2,911 | 3,110 | +140 | +4.7% | 806,600 |
2020/07/02 | 3,205 | 3,235 | 2,922 | 2,970 | -205 | -6.5% | 1,404,900 |
2020/07/01 | 3,190 | 3,275 | 3,120 | 3,175 | +5 | +0.2% | 576,900 |
2020/06/30 | 3,350 | 3,365 | 2,900 | 3,170 | -140 | -4.2% | 1,157,500 |
2020/06/29 | 3,235 | 3,370 | 3,225 | 3,310 | +5 | +0.2% | 680,200 |
2020/06/26 | 3,430 | 3,430 | 3,300 | 3,305 | -80 | -2.4% | 756,600 |
2020/06/25 | 3,365 | 3,530 | 3,250 | 3,385 | -50 | -1.5% | 2,301,300 |
2020/06/24 | 3,335 | 3,690 | 3,255 | 3,435 | +105 | +3.2% | 3,722,700 |
2020/06/23 | 3,750 | 3,820 | 3,305 | 3,330 | -370 | -10% | 5,680,200 |
2020/06/22 | 2,964 | 3,700 | 2,961 | 3,700 | +700 | +23.3% | 9,481,100 |
2020/06/19 | 2,519 | 3,000 | 2,513 | 3,000 | +500 | +20% | 1,919,600 |
2020/06/18 | 2,605 | 2,623 | 2,468 | 2,500 | -115 | -4.4% | 1,747,700 |
2020/06/17 | 2,617 | 2,800 | 2,517 | 2,615 | +298 | +12.9% | 8,426,200 |
2020/06/16 | 2,317 | 2,317 | 2,317 | 2,317 | +400 | +20.9% | 47,500 |
2020/06/15 | 2,077 | 2,184 | 1,900 | 1,917 | -159 | -7.7% | 1,107,000 |
2020/06/12 | 1,982 | 2,114 | 1,956 | 2,076 | -49 | -2.3% | 1,511,400 |
2020/06/11 | 2,263 | 2,298 | 2,100 | 2,125 | -179 | -7.8% | 2,075,300 |
2020/06/10 | 2,074 | 2,450 | 2,040 | 2,304 | +156 | +7.3% | 3,766,500 |
2020/06/09 | 2,050 | 2,177 | 2,007 | 2,148 | +101 | +4.9% | 1,883,100 |
2020/06/08 | 2,099 | 2,100 | 2,003 | 2,047 | +61 | +3.1% | 1,396,300 |
2020/06/05 | 2,018 | 2,160 | 1,967 | 1,986 | -100 | -4.8% | 4,637,900 |
2020/06/04 | 1,992 | 2,086 | 1,941 | 2,086 | +400 | +23.7% | 5,838,600 |
2020/06/03 | 1,700 | 1,702 | 1,633 | 1,686 | -4 | -0.2% | 440,700 |
2020/06/02 | 1,675 | 1,744 | 1,657 | 1,690 | +30 | +1.8% | 710,700 |
2020/06/01 | 1,650 | 1,673 | 1,611 | 1,660 | +12 | +0.7% | 400,600 |
2020/05/29 | 1,650 | 1,681 | 1,626 | 1,648 | -2 | -0.1% | 441,600 |
2020/05/28 | 1,700 | 1,721 | 1,604 | 1,650 | -90 | -5.2% | 1,336,900 |
2020/05/27 | 1,647 | 1,889 | 1,630 | 1,740 | +173 | +11% | 6,046,500 |
1151~
1200
件表示中 / 2776件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 57,500円 | +3771.0% | - | 0.00% | - | 5.21倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステムリム | 32,300円 | - | - | 0.00% | - | 2.97倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
Chordia | 25,900円 | - | - | 0.00% | - | 5.51倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
大幸薬品 | 27,400円 | +0.1% | -70.9% | 0.00% | 45.82倍 | 1.73倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
レナサイエンス | 103,600円 | -34.5% | - | 0.00% | 286.18倍 | 8.60倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
市場注目の銘柄
チャート関連のコラム